Related Experiment Video
Updated: Nov 15, 2025

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3
Published on: December 27, 2010
HIV in Canada-surveillance report, 2019
Nisrine Haddad1, Ashley Weeks1, Anita Robert1
1Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.
New HIV diagnoses in Canada remained stable from 2010-2019, with gay, bisexual, and other men who have sex with men (gbMSM) and people who inject drugs (PWID) representing a high proportion of cases.
Area of Science:
- Public Health
- Epidemiology
- Infectious Diseases
Background:
- Human Immunodeficiency Virus (HIV) is a significant global health concern.
- HIV has been a notifiable disease in Canada since 1985.
- The Public Health Agency of Canada (PHAC) actively monitors new HIV diagnoses.
Purpose of the Study:
- To present an epidemiological overview of reported HIV cases in Canada for 2019.
- To analyze 10-year trends in HIV diagnoses from 2010 to 2019.
- To include data on HIV diagnoses through Immigration Medical Exams (IME) and perinatal transmission.
Main Methods:
- Utilized the HIV/AIDS Surveillance System, a passive, case-based data collection system.
- Conducted descriptive analyses on national HIV data.
- Incorporated data from Immigration, Refugees and Citizenship Canada (IRCC) and the Canadian Perinatal HIV Surveillance Program.
Main Results:
- In 2019, Canada reported 2,122 new HIV diagnoses (5.6 per 100,000 population).
- Saskatchewan had the highest provincial diagnosis rate (16.9 per 100,000).
- Gay, bisexual, and other men who have sex with men (gbMSM) accounted for the highest proportion of adult cases with known exposure (39.7%), followed by heterosexual contact (28.3%) and people who inject drugs (PWID, 21.5%).
Conclusions:
- HIV diagnoses in Canada have remained relatively stable over the past decade.
- gbMSM and PWID populations continue to represent a significant proportion of new HIV diagnoses.
- Ongoing surveillance is crucial for meeting pan-Canadian goals to reduce the impact of sexually transmitted and blood-borne infections by 2030.
More Related Videos
13:12Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays
Published on: April 4, 2011
07:10Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
Published on: September 14, 2014
Related Concept Videos
Principles of Disease Surveillance
Sexually Transmitted Infections
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Subviral Agents
Retrovirus Life Cycles